SCHEMBL1633533

SCHEMBL1633533

NS(=O)(=O)c1ccc(Nc2ncc3ccc(OCCC4CCNCC4)cc3n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 4/20 0.44
CHUK O15111 1/20 0.43
CDK1 P06493 7/20 0.42
CDK2 P24941 6/20 0.42
CCNA2 P20248 3/20 0.42
CCNA1 P78396 1/20 0.42
SYK P43405 3/20 0.41
JAK2 O60674 1/20 0.41
IGF1R P08069 1/20 0.41
CCNT1 O60563 5/20 0.41
CDK7 P50613 5/20 0.41
CDK9 P50750 5/20 0.41
CCNB1 P14635 3/20 0.41
CCNH P51946 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
CDK5 Q00535 2/20 0.41
CA12 O43570 1/20 0.41
STK4 Q13043 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633527 0.91 IKBKB (0.51) IKBKBCHUKCDK1CDK2CCNA2
SCHEMBL1632449 0.86 CDK2 (0.42) IKBKBCHUKCDK1CDK2CCNA2
SCHEMBL1632828 0.85 IKBKB (0.48) IKBKBCHUKCDK1CDK2SYK
SCHEMBL1632515 0.80 SYK (0.53) IKBKBCHUKCDK1CDK2CCNA2
SCHEMBL1633423 0.79 IKBKB (0.63) IKBKBCDK1CDK2CCNA2CCNA1
SCHEMBL1633099 0.77 IKBKB (0.65) IKBKBCDK1CDK2CCNT1CDK7
SCHEMBL1571219 0.76 IKBKB (0.48) IKBKBCDK1CDK2SYKCCNT1
SCHEMBL1634724 0.74 IKBKB (0.62) IKBKBCDK1CDK2CCNA2CCNT1
SCHEMBL1633106 0.74 IKBKB (0.49) IKBKBCDK2CCNA2CCNA1CA1
SCHEMBL12724976 0.74 CDK2 (0.43) IKBKBCDK2SYKJAK2STK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed